FDA Approves Takeda's Actoplus Met
Actoplus Met is a combination of two oral diabetes medicines that help control blood sugar levels. Actoplus Met is for people with type 2 diabetes who do not use daily insulin injections. This medication is not for treating type 1 diabetes.
Actoplus Met is commonly prescribed to treat type 2 diabetes in adults. The medication combines pioglitazone and metformin, two diabetes drugs that decrease the amount of sugar absorbed into the body and help improve insulin sensitivity. The product comes in tablet form and is usually taken once or twice a day. Possible side effects include nausea, upper respiratory tract infections, and weight gain.
This combination medication is used along with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes (non-insulin-dependent diabetes). This medication works by helping to restore your body's proper response to the insulin you naturally produce. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone belongs to a class of drugs known as thiazolidinediones or "glitazones". Metformin is a biguanide-type drug.
ACTOplus met is used to treat type 2 diabetes. It contains two medications, pioglitazone and metformin, that work together to help keep blood sugar levels under control. Type 2 diabetes usually stems from the body's inability to make good use of insulin, the natural hormone that helps to transfer sugar out of the blood and into the cells, where it's converted to energy. ACTOplus met works by improving your body's response to its own natural insulin supply. It also helps decrease sugar production and absorption.